The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.

The highest priority should be adults with BMI over 35 or those with BMI over 30, who also have severe obesity-related ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A subdivision of the American Diabetes Association has begun publishing a document that aims to ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...